News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CSPC PHARMA Extends Gains to ~3%; 2025 Rev. Drops 10.4%, but Final DPS Added
CSPC PHARMA (01093.HK) closed up 1% at midday. The Group announced at noon that its 2025 profit fell by 10.3%, but it increased its final dividend. The stock’s gains expanded...
Reset
Send
The window will close in 5 seconds
CSPC PHARMA Extends Gains to ~3%; 2025 Rev. Drops 10.4%, but Final DPS Added
Close
Recommend
11
Positive
25
Negative
12
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

CSPC PHARMA (01093.HK)  +0.090 (+0.936%)    Short selling $314.42M; Ratio 92.374%   closed up 1% at midday. The Group announced at noon that its 2025 profit fell by 10.3%, but it increased its final dividend. The stock’s gains expanded in the afternoon session. It last printed at $8.57, jumping up 2.88%, with a trading volume of 54.0849 million shares, involving $460 million.

CSPC PHARMA reported a revenue of RMB26.006 billion, down 10.4% YoY. Profit attributable to shareholders was RMB3.882 billion, down 10.3% YoY, with an EPS of RMB0.3398. A final DPS of $0.15 was declared, compared to $0.10 in the same period last year. Including the interim DPS of $0.14, the total annual DPS was $0.29, up 11.5% YoY.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.